Status:

COMPLETED

VA Nutrition Study on Immune Function

Lead Sponsor:

US Department of Veterans Affairs

Collaborating Sponsors:

University of Oklahoma

Conditions:

Malnutrition

Infection

Eligibility:

All Genders

55+ years

Brief Summary

Hospital-acquired infections can occur five times as frequently in rehabilitation patients than in other hospital admissions. We postulate that this high infection rate may be due to nutritional probl...

Detailed Description

Background: Hospital-acquired infections can occur five times as frequently in rehabilitation patients than in other hospital admissions. We postulated that this high infection rate may be due to nut...

Eligibility Criteria

Inclusion

  • Patients must be in inpatient rehabilitation, be \> 55 years old, and must not suffer any of the following: on active antibiotics; chart documented malignancy, immunodeficiency (HIV, steroid treatment, plasma cell dyscrasia), advanced CHF or malabsorption syndromes (inflammatory bowel diseases such as colitis or Crohn's disease, celiac sprue, gastrectomy, bowel resection, irritable bowel syndrome, complicated diverticulitis, internal fistulae) affecting nutritional status; anemia (Hct\<25%), renal failure (serum creatinine \> 3.0 mg/dl), liver failure (alk phosp \>3x norm or bilirubin \>10mg/100ml); estimated LOS \<3 months; unable to comply with study procedures.

Exclusion

  • known pre-existing infection requiring antibiotic treatment (e.g. TB, osteomyelitis, SBE) chart documented malignancy, immunodeficiency (e.g. HIV infection, steroid treatment, plasma cell dyscrasia), advanced CHF or malabsorption syndromes (inflammatory bowel diseases such as colitis or Crohn's disease, celiac sprue, gastrectomy, bowel (ileal) resection, irritable bowel syndrome, complicated diverticulitis, or internal fistulae) directly affecting nutritional status documented anemia (Hct \<25%), renal (serum creatinine \>3.0 mg/dl), or liver failure (SGPT or alkaline phosphatase \>3 times normal or bilirubin \>10mg/100mL).
  • estimated admission \<3 months or noncompliance with study procedures (unable/unwilling to perform study procedures)

Key Trial Info

Start Date :

March 1 2003

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2007

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00105625

Start Date

March 1 2003

End Date

September 1 2007

Last Update

April 7 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Oklahoma City VA Medical Center, Oklahoma City, OK

Oklahoma City, Oklahoma, United States, 73104